← All trials
NCT06781879
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 24, 2025
- Primary completion
- Feb 1, 2029
- Completion date
- Feb 1, 2032
- First posted
- Jan 17, 2025
- Last posted
- Jan 20, 2025
- Enrollment
- 272
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aarhus UniversityLead sponsor
- Aarhus UniversitySponsor investigator
- Danish Cancer SocietyCollaborator
- MedacCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.